IP Library › Granted Patent US 10,941,388
Granted Patent B2
US 10,941,388 · App. 15/985,216 · Granted Mar 9, 2021

Cellulase complex, and glycosidase hydrolases thereof, and methods of using thereof

Inventors: Steven W. Singer (Oakland, CA); Sebastian D. Kolinko (Basel, CH); Evelyn Denzel (Laupheim, DE); Jennifer Hiras (Corning, NY); John M. Gladden (Alameda, CA)
Assignees: The Regents of the University of California; National Technology & Engineering Solutions of Sandia, LLC
C12N9/2437C12N9/2402C12N9/2482C12N9/2491C12P7/649C12P19/02C12P19/14C12N15/63C12Y302/01004C12Y302/01008C12Y302/01025Y02E50/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,941,388
App. No.
15/985,216
Granted
Mar 9, 2021
Kind
B2
Abstract

The present invention provides for a purified or isolated cellulase complex comprising two or more glycosidase hydrolase, or enzymatically active fragment thereof, selected from the group consisting of a GH9 polypeptide, a GH48 polypeptide, a GH10 polypeptide, and a GH6 polypeptide, and optionally a GH10_2 polypeptide and/or an AA10 polypeptide.

Claims (8)

1. A composition comprising an ionic liquid and a purified or isolated cellulase complex comprising two or more glycosidase hydrolases selected from the group consisting of a glycoside hydrolase 9 (GH9) polypeptide comprising an amino acid sequence at least 90% identical to SEQ ID NO:1 and the following amino acid sequences: SGKLP (SEQ ID NO:13), WRGDS (SEQ ID NO:14), DLTGGW (SEQ ID NO:15), DAGDHVKF (SEQ ID NO:16), WAVYEY (SEQ ID NO:17), DHAWWGPA (SEQ ID NO:18), EVMQM (SEQ ID NO:19), AVWLYLAT (SEQ ID NO:20), WDDVH (SEQ ID NO:21), GLAWLD (SEQ ID NO:22), WGSLRYA (SEQ ID NO:23), FLAFVYSDW (SEQ ID NO:24), RPHHRTAH (SEQ ID NO:25), and SWADSQ (SEQ ID NO:26), a glycoside hydrolase 48 (GH48) polypeptide comprising an amino acid sequence at least 90% identical to SEQ ID NO:2 and the following amino acid sequences: PANGYF (SEQ ID NO:27), GIPYHS (SEQ ID NO:28), EAPDYGH (SEQ ID NO:29), TTSEAFSY (SEQ ID NO:30), TGDWSK (SEQ ID NO:31), PATYA (SEQ ID NO:32), DVDNWYG (SEQ ID NO:33), NTFQRG (SEQ ID NO:34), ESVWE (SEQ ID NO:35), QWRYT (SEQ ID NO:36), DADARAIQ (SEQ ID NO:37), KMGDYLRY (SEQ ID NO:38), FDKYF (SEQ ID NO:39), SAHYLLSWY (SEQ ID NO:40), GYQNP (SEQ ID NO:41), GGATNS (SEQ ID NO:42), TFYGM (SEQ ID NO:43), PVYRDP (SEQ ID NO:44), WFGFQAWS (SEQ ID NO:45), GQPDTW (SEQ ID NO:46), YTGNPN (SEQ ID NO:47), and YHRFWAQ (SEQ ID NO:48), a glycoside hydrolase 10 (GH10) polypeptide comprising an amino acid sequence identical to SEQ ID NO:3, and a glycoside hydrolase 6 (GH6) polypeptide comprising an amino acid sequence identical to SEQ ID NO:4.

2. The composition of claim 1 , wherein the purified or isolated cellulase complex further comprises a glycoside hydrolase 10_2 (GH10_2) polypeptide comprising an amino acid sequence at least 90% identical to SEQ ID NO:5, wherein the amino acid sequence comprises the following amino acid sequences: ADAGLA (SEQ ID NO:49), KFLGNVI (SEQ ID NO:50), YWNQVTPEN (SEQ ID NO:51), TKWGSVE (SEQ ID NO:52), SNGFPFKFHTLVWGSQ (SEQ ID NO:53), PGWISGLS (SEQ ID NO:54), WIQAAGQRYP (SEQ ID NO:55), ADFVDWNEPLHAKPSYRNAIGGDG (SEQ ID NO:56), TGWDWVIWSF (SEQ ID NO:57), KLLINEYG (SEQ ID NO:58), DPNAA (SEQ ID NO:59), QYVQIINLLKSRGLIDGIGIQ (SEQ ID NO:60), VSVST (SEQ ID NO:61), TGLPIYVSELD (SEQ ID NO:62), TQLARYQ (SEQ ID NO:63), TLWGYIEGQTW (SEQ ID NO:64), and ERPALQWLRTYL (SEQ ID NO:65).

3. The composition of claim 1 , wherein the purified or isolated cellulase complex further comprises an auxiliary activity 10 (AA10) polypeptide comprising an amino acid sequence at least 90% identical to SEQ ID NO:6, wherein the amino acid sequence comprises the following amino acid sequences: MNRRLIARLSGMLAMVLIAA (SEQ ID NO:66), LAYVPKPEPAEAHGGMVFPATRTYACYVDGKVHGNGGDLNMINPACLDALAIS GNYQFWNWFGNLISNAGGRHREIIPDGKLCGPTASFDGMNQARTDWWTTRLQ PGATITVRVNAWAPHPGTWYLYVTRDGWDPTQPLKWSDLEPTPFSQVTNPPIN SSGPDGAEYSWQVQLPNKQGRHIIYMIWQRSDSPEAFYNCSD (SEQ ID NO:67), and YFGSGPIAYEFGDPREGGT (SEQ ID NO:68).

4. The composition of claim 1 , wherein the purified or isolated cellulase complex comprises: (a) the GH9 polypeptide comprising an amino acid sequence at least 90% identical to SEQ ID NO:1 and the following amino acid sequences: SGKLP (SEQ ID NO:13), WRGDS (SEQ ID NO:14), DLTGGW (SEQ ID NO:15), DAGDHVKF (SEQ ID NO:16), WAVYEY (SEQ ID NO:17), DHAWWGPA (SEQ ID NO:18), EVMQM (SEQ ID NO:19), AVWLYLAT (SEQ ID NO:20), WDDVH (SEQ ID NO:21), GLAWLD (SEQ ID NO:22), WGSLRYA (SEQ ID NO:23), FLAFVYSDW (SEQ ID NO:24), RPHHRTAH (SEQ ID NO:25), and SWADSQ (SEQ ID NO:26); (b) the GH48 polypeptide comprising an amino acid sequence at least 90% identical to SEQ ID NO:2 and the following amino acid sequences: PANGYF (SEQ ID NO:27), GIPYHS (SEQ ID NO:28), EAPDYGH (SEQ ID NO:29), TTSEAFSY (SEQ ID NO:30), TGDWSK (SEQ ID NO:31), PATYA (SEQ ID NO:32), DVDNWYG (SEQ ID NO:33), NTFQRG (SEQ ID NO:34), ESVWE (SEQ ID NO:35), QWRYT (SEQ ID NO:36), DADARAIQ (SEQ ID NO:37), KMGDYLRY (SEQ ID NO:38), FDKYF (SEQ ID NO:39), SAHYLLSWY (SEQ ID NO:40), GYQNP (SEQ ID NO:41), GGATNS (SEQ ID NO:42), TFYGM (SEQ ID NO:43), PVYRDP (SEQ ID NO:44), WFGFQAWS (SEQ ID NO:45), GQPDTW (SEQ ID NO:46), YTGNPN (SEQ ID NO:47), and YHRFWAQ (SEQ ID NO:48); (c) the GH10 polypeptide comprising an amino acid sequence identical to SEQ ID NO:3; and (d) the GH6 polypeptide comprising an amino acid sequence identical to SEQ ID NO:4.

5. The composition of claim 1 , wherein the concentration of IL in the composition is equal to or more than 1%.

6. The composition of claim 4 , wherein (a) the GH9 polypeptide comprises an amino acid sequence at least 95% identical to SEQ ID NO:1; and (b) the GH48 polypeptide comprises an amino acid sequence at least 95% identical to SEQ ID NO:2.

7. The composition of claim 6 , wherein (a) the GH9 polypeptide comprises an amino acid sequence at least 99% identical to SEQ ID NO:1; and (b) the GH48 polypeptide comprises an amino acid sequence at least 99% identical to SEQ ID NO:2.

8. The composition of claim 7 , wherein (a) the GH9 polypeptide comprises an amino acid sequence identical to SEQ ID NO:1; and (b) the GH48 polypeptide comprises an amino acid sequence identical to SEQ ID NO:2.

Assignments (3)
CONFIRMATORY LICENSE Recorded Apr 3, 2019
From: UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB
To: UNITED STATES DEPARTMENT OF ENERGY
Reel/Frame 048786/0119 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2018
From: SINGER, STEVEN W.; KOLINKO, SEBASTIAN D.; DENZEL, EVELYN; HIRAS, JENNIFER
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 047658/0527 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2018
From: GLADDEN, JOHN M.
To: NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC
Reel/Frame 046755/0916 →
Continuity (3)
Continuation PCTUS2016063198 · Nov 21, 2016
Provisional Application 62257477 · Nov 19, 2015
Related Publication 20180371443A1 · Dec 27, 2018